Government Pause Johnson and Johnson Vaccine

Government Officials have recommended a pause in the use of the Johnson and Johnson Covid-19 and the FDA announced today that they are reviewing 6 reported cases of a rare and severe type of blood clot. The Agencies say 6.8 million doses have been administered in the US officials say these adverse reactions are extremely rare and are continuing to investigate these cases.